
-
Erased identity: Post-war adoptee seeks German roots
-
Struggling Sevilla sack Garcia Pimienta
-
Japan qualify for BJK Cup finals with win over Canada
-
Iran says talks with US to focus solely on nuclear issue, lifting sanctions
-
Members of Hong Kong's Democratic Party approve plan to disband
-
Russian strike on city centre in Ukraine's Sumy kills 21
-
Green Day, Charli XCX and... Bernie Sanders helm Coachella day two
-
Hirpa and Biwott triumph at Paris Marathon
-
China's Xi courts Southeast Asia as Trump tariffs bite
-
Gaza hospital hit as Israel intensifies assault
-
Myanmar quake victims mark new year camped in ruins
-
Australian schoolboy Gout Gout scorches to 19.84sec over 200m
-
Bernie Sanders fights apathy on American left
-
Scottish rowing brothers aim for record-breaking Pacific crossing
-
Ennis downs Stanionis to unify IBF, WBA welterweight belts
-
Bernie Sanders thrills Coachella crowd with surprise appearance
-
Bulgarian border city hails Schengen tourism boom
-
Algeria protests after consular official indicted in France
-
Indonesia palm oil firms eye new markets as US trade war casts shadow
-
Indonesia's horror movie industry rises from the grave
-
Myanmar marks new year festival mourning quake losses
-
Death toll in Dominican nightclub roof collapse hits 226
-
Blues go back to forwards to turn around Super Rugby form
-
Harvey Weinstein sex crimes retrial to begin Tuesday in NY
-
Hip hop trio Kneecap has Coachella rapping in Irish
-
Day: McIlroy worthy of Tiger and Jack if he wins Masters
-
Ecuador votes in razor-close presidential runoff
-
DeChambeau surges late to line up Masters showdown with McIlroy
-
McIlroy eyes Masters win and Slam - 'I'll be able to handle it'
-
World Expo opens in Japan in rocky times
-
McIlroy leads by two heading into Masters final round
-
No.1 Scheffler grinds out level par on tough day at Masters
-
Ecuador's presidential hopefuls face toxic brew of crime, unemployment
-
Over 100 feared dead in Sudan paramilitary attacks in Darfur: UN
-
Ex-ministers charged as probe into deadly club fire broadens
-
Magisterial McIlroy leads midway through Masters third round
-
Own goal helps Liga leaders Barca beat Leganes
-
Svitolina seals Ukraine berth in BJK Cup Finals with Britain, Spain advancing
-
Marc Marquez fires warning with MotoGP Qatar sprint victory
-
McLaren's Piastri claims Bahrain pole as Norris, Verstappen struggle
-
UK government to take control of British Steel under emergency law
-
Serbian president holds nationalist rally to counter student demos
-
Bayern fail to make most of Leverkusen slip with Dortmund draw
-
Ailing Bolsonaro says he will 'probably' need surgery
-
Arnautovic pushes Inter six points clear ahead of Bayern showdown
-
Zach Johnson, 49, turns back time with 66 in Masters charge
-
Sizzling start lifts McIlroy to Masters lead
-
Abhishek plunders 141 as Hyderabad pull off second-highest IPL chase
-
Serbian president holds nationalist counter-rally
-
Arsenal held by Brentford as faint title hopes fade

US panel weighs authorizing Covid vaccines for youngest children
After months of anxious wait for some parents, a panel of experts convened by the US Food and Drug Administration will meet Wednesday to weigh recommending Covid vaccines for the nation's youngest children.
Children under five are the only age group not yet eligible for Covid immunization in the United States and most other countries. If, as expected, panelists vote in favor of greenlighting the Pfizer and Moderna vaccines, formal authorizations should follow quickly, with the first shots in arms expected by next week.
Ahead of the meeting, the FDA posted its independent analyses of the two drugs, deeming both safe and effective. It also said there was a pressing unmet need to inoculate children in the age group since their rates of hospitalization and death "are higher than among children and adolescents 5-17 years of age."
Both vaccines are based on messenger RNA technology, which delivers genetic code for the coronavirus spike protein to human cells, training the immune system to be ready for when it encounters the real virus.
Pfizer is seeking authorization for three doses at three micrograms given to ages six months through four years, while Moderna has asked for the FDA to approve its vaccine as two doses of a higher 30 micrograms, for ages six months through five years.
They were tested in trials of thousands of children where they were found to have similar levels of mild effects to older age groups and triggered similar levels of antibodies.
Efficacy against infection was higher for Pfizer, with the company placing it at 80 percent compared to Moderna's estimates of 51 percent in the six-month-old to age two group and 37 percent in the two to five years age group.
But the figures are provisional and Moderna is studying adding a third dose later that may increase its figures.
There are some 20 million US children aged four years and under. If the FDA-appointed experts recommend the two vaccines, then the matter will go to another committee convened by the Centers for Disease Control and Prevention for a final say.
White House officials last week said the rollout of millions of shots at pharmacies and doctors' offices could begin as soon as June 21, following the Juneteenth holiday on June 20.
Of the total US Covid deaths, 480 have come in children under five, according to the latest official data.
Obesity, neurological disorders and asthma are associated with increased risk of severe disease, "however, a majority of children hospitalized for Covid-19 have no underlying medical conditions," the FDA said in a document.
Children can also go on to contract multisystem inflammatory syndrome in children (MIS-C), a rare but serious post-viral condition.
Data on long Covid in children is sparse, but the FDA's document cited a national survey in the United Kingdom which found that "among children ages two to 11 years who tested positive for COVID-19, 7.2 percent reported continued symptoms at 12 weeks."
D.Johnson--AT